Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome
about
Modulation of host lipid metabolism by hepatitis C virus: Role of new therapiesThe evolution of natural killer cell receptorsNatural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experienceDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Associations of human leucocyte antigen class II-DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family-based study.Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patientsPeptide antagonism as a mechanism for NK cell activation.Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremiaThe efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter?Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses.Activation of natural killer cells during acute infection with hepatitis C virus.Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infectionThe relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected womenKIR/HLA interactions and pathogen immunityHost genetic determinants of spontaneous hepatitis C clearance.NK cells, innate immunity and hepatitis C infection after liver transplantation.KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.Role of host genetic factors in the outcome of hepatitis C virus infection.A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.Structural insights into activation of antiviral NK cell responsesThe Yin and Yang of HLA and KIR in human diseaseNatural killer cells: multifaceted players with key roles in hepatitis C immunity.Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation.Role of KIR genes and genotypes in susceptibility to or protection against hepatitis B virus infection in a Turkish cohort.Host genetics in immune-mediated hepatitis C virus clearance.NK cells prevalence, subsets and function in viral hepatitis C.Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.Human diversity of killer cell immunoglobulin-like receptors and disease.Genomic variation-guided management in chronic hepatitis C.Innate and adaptive genetic pathways in HCV infection.NK cells: tuned by peptide?Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil.High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults.A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation.
P2860
Q26782009-4C86E92C-3F2F-416D-B1EF-E7E00EB26274Q26782592-38C966EF-CC3C-42B9-8D47-4A78EF7DFA67Q26850968-EBF194A9-EEE5-47D1-BA7C-02B3451D4A96Q27010312-9508409D-FA75-4A80-B25C-C0E05B5DE4F9Q30392599-70B1B0D4-2A6D-4B04-8E03-311B222A9088Q30413217-B5E3ED0A-305F-4472-9E66-F8A0EB439729Q33565605-5755ACE0-78EA-4919-837D-53D8A0B15B1EQ33796039-CEB3F354-D23C-4299-B8CE-B2BFE9BAE606Q33933479-0355B7A6-E3F5-427B-A86A-4955E5700658Q34078846-736973CA-C9C9-40DA-8905-8A66107D2678Q34158520-10E5D71B-BEBB-478C-80D2-657DF21BCCA6Q34181287-CAE3F85D-5115-498C-AD86-9E243DBA83F7Q34258994-868FD07D-F53D-4DE2-B6FB-431B3CD72F8AQ34283615-F702E065-F31A-47CC-B40E-3FB06ECCA406Q34365617-8B87458F-60E5-4F89-A3DB-8B8153A5B616Q34949587-4D41B8BE-B857-4AA8-B7FB-9AFEC90A3787Q35000910-6DB748DC-1E57-4809-A2A9-82253BA2E943Q35001169-4A8BFF2A-6BC4-4F7D-9975-13F222853C2CQ35011376-3AA5DF2F-6F7C-43DC-B070-8F6A0C8743B3Q35019869-68394063-6D22-4DC9-B42B-840CBDF59794Q35070933-7E42EBE0-2BE2-4BDA-8EB4-2E548752558AQ35259735-74E041C5-115D-4A5B-84FD-E75DD29722DEQ35356926-872D8692-07AC-4AED-B05D-4016DA0FB8DFQ36317668-C8179EF0-483C-444D-B499-DBD90FBD7F9FQ36410540-E580ACF0-8A90-4378-A140-1133E84FEB13Q37151472-C40DD07B-BC9F-498D-B6B5-9B357DD9966FQ37240705-FDF20A67-F2B2-41D1-94AC-6934B385FB73Q37405194-B722A5A7-3403-4F31-B2B9-74C01BDFEF32Q37490445-031FE1C3-50AE-499F-ADC5-FAFD33AC1EC3Q37862746-ED92FF34-EA44-4E42-8A2D-1C599D25FDAAQ37942504-937DEB75-20DA-4495-8108-2CA09ED58327Q37964746-E406BCB9-A830-4568-B3E9-0EC2383E2E19Q37977062-A47F6028-D5F9-4D8E-900E-4CF9DC0D1ABFQ38038693-B3EE7269-A12C-493C-B86C-7FFA1E780EA9Q38364524-6B8F4338-5463-41A2-986C-033C061A4E0EQ38568884-C930F752-D102-40A4-BCE1-E02EF7096FD9Q39372538-905430E7-363E-41D7-BDE5-DB8BE236A434Q39555726-4BE4C834-9012-4933-BD6B-AF4E5466B6F7Q40109884-F8603103-B756-4754-8D69-D0E8C164D18EQ40851782-C5092BD9-AE29-44B0-BA1D-E655848A0F16
P2860
Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Interaction of NK inhibitory r ...... itis C virus infection outcome
@ast
Interaction of NK inhibitory r ...... itis C virus infection outcome
@en
Interaction of NK inhibitory r ...... itis C virus infection outcome
@nl
type
label
Interaction of NK inhibitory r ...... itis C virus infection outcome
@ast
Interaction of NK inhibitory r ...... itis C virus infection outcome
@en
Interaction of NK inhibitory r ...... itis C virus infection outcome
@nl
prefLabel
Interaction of NK inhibitory r ...... itis C virus infection outcome
@ast
Interaction of NK inhibitory r ...... itis C virus infection outcome
@en
Interaction of NK inhibitory r ...... itis C virus infection outcome
@nl
P2093
P2860
P1433
P1476
Interaction of NK inhibitory r ...... itis C virus infection outcome
@en
P2093
Christopher Amos
Daniel Terreros
Edmond J Yunis
Joaquin Zúñiga
Jose Azocar
Olga P Clavijo
Raymond T Chung
Viviana Romero
Xiangjun Gu
Zaheed Husain
P2860
P304
P356
10.1016/J.MOLIMM.2008.01.002
P577
2008-05-01T00:00:00Z